PNC Financial Services Group
ATOS icon

PNC Financial Services Group’s Atossa Therapeutics ATOS Stock Holding History

PNC Financial Services Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 4761
2022
Q3 		– Hold
0
– – – 4438
2022
Q2 		– Sell
-17
Closed – – 4473
2022
Q1 		$0 Buy
+17
New +$345 ﹤0.01% 4512
2020
Q1 		– Sell
-4
Closed – – 3886
2019
Q4 		$0 Hold
4
– – ﹤0.01% 3978
2019
Q3 		$0 Hold
4
– – ﹤0.01% 3983
2019
Q2 		$0 Hold
4
– – ﹤0.01% 4005
2019
Q1 		$0 Hold
4
– – ﹤0.01% 4020
2018
Q4 		$0 Hold
4
– – ﹤0.01% 4028
2018
Q3 		$0 Buy
+4
New +$131 ﹤0.01% 4110
2016
Q3 		– Sell
-2
Closed -$1K – 3978
2016
Q2 		$1K Hold
2
– – ﹤0.01% 4332
2016
Q1 		$1K Hold
2
– – ﹤0.01% 4343
2015
Q4 		$1K Sell
2
-9
-82% -$13.8K ﹤0.01% 4305
2015
Q3 		$22K Hold
11
– – ﹤0.01% 3318
2015
Q2 		$32K Buy
11
+9
+450% +$35.9K ﹤0.01% 3264
2015
Q1 		$8K Hold
2
– – ﹤0.01% 3848
2014
Q4 		$6K Sell
2
-3
-60% -$8.46K ﹤0.01% 3481
2014
Q3 		$19K Hold
5
– – ﹤0.01% 3066
2014
Q2 		$23K Hold
5
– – ﹤0.01% 2878
2014
Q1 		$24K Buy
5
+1
+25% +$5.92K ﹤0.01% 2789
2013
Q4 		$22K Buy
4
+2
+100% +$13.2K ﹤0.01% 2770
2013
Q3 		$33K Buy
+2
New +$26.2K ﹤0.01% 2646

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

PNC Financial Services Group's ATOS Position: Q4 2022 in Review

PNC Financial Services Group held its Atossa Therapeutics (ATOS) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4761.

PNC Financial Services Group first reported a position in ATOS in Q3 2013 and has held it in 19 quarters since. The position peaked at $33K in Q3 2013. 51 funds tracked by Wall St. Rank hold ATOS as of Q4 2022.

  • PNC Financial Services Group held 0 shares of Atossa Therapeutics worth $0 as of Q4 2022.
  • PNC Financial Services Group left its Atossa Therapeutics share count unchanged in Q4 2022.
  • Atossa Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q4 2022, its #4761 holding.
  • PNC Financial Services Group first reported a position in Atossa Therapeutics in Q3 2013 and has held it in 19 quarters since.
  • PNC Financial Services Group's Atossa Therapeutics position peaked at $33K in Q3 2013.
  • 51 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.